×
Vaso Price to Free Cash Flow Ratio 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Vaso price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
View More
Vaso Price to Free Cash Flow Ratio 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Vaso price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.5B
Intuitive Surgical (ISRG)
$174.1B
Alcon (ALC)
$48.6B
IQVIA Holdings (IQV)
$43.5B
Edwards Lifesciences (EW)
$41.3B
IDEXX Laboratories (IDXX)
$41.2B
DexCom (DXCM)
$27.9B
STERIS (STE)
$24.1B
SONOVA HOLDING (SONVY)
$21.4B
Waters (WAT)
$19.3B
Hologic (HOLX)
$18.8B
Fresenius Medical Care AG KGaA (FMS)
$12.4B
Sysmex ADR (SSMXY)
$12.4B
Teleflex (TFX)
$11.6B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.3B
Glaukos (GKOS)
$6.9B
Masimo (MASI)
$6B
TransMedics (TMDX)
$5.1B
Integer Holdings (ITGR)
$4.3B
PROCEPT BioRobotics (PRCT)
$4.2B
Tandem Diabetes Care (TNDM)
$2.9B
Inari Medical (NARI)
$2.7B
LivaNova (LIVN)
$2.6B
Veracyte (VCYT)
$2.5B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.5B
RxSight (RXST)
$2B
Integra LifeSciences Holdings (IART)
$1.4B
Pulse Biosciences (PLSE)
$1.1B